Suppr超能文献

[地塞米松在儿童化脓性脑膜炎中的价值。关于85例儿童的比较研究]

[Value of dexamethasone in purulent meningitis in children. Apropos of a comparative study of 85 children].

作者信息

Marguet C, Mallet E

机构信息

Service de Pédiatrie, Centre Hospitalo-Universitaire, Hôpital Charles-Nicolle, Rouen.

出版信息

Arch Fr Pediatr. 1993 Feb;50(2):111-7.

PMID:8343015
Abstract

BACKGROUND

The beneficial effect of dexamethasone plus antibiotic therapy in bacterial meningitis is still controversial.

PATIENTS AND METHODS

Eighty-five children, aged 1 month to 14 years, were admitted between 1987 and 1990 for bacterial meningitis. They received the same antibiotic therapy for 10 days (7 days in meningococcal meningitis). The 44 children admitted since March 1989 were also given dexamethasone (0.15 mg/kg/6 hours for 4 days); the first injection was given before antibiotic therapy. Clinical (fever, neurological findings, audition) and laboratory data [CSF proteins, glucose, lactate, cell and bacterial counts; blood C-reactive protein (CRP), hemoglobin, leukocytes and platelets] were analyzed statistically.

RESULTS

The group treated with antibiotics plus dexamethasone showed decreases significantly greater in CSF protein and lactate levels after 48 hours than the children given antibiotics alone and an early (6 hours after the start of treatment) increase in CSF glucose. The blood CRP level of the dexamethasone plus antibiotics group decreased significantly within 48 hours. The numbers of neurological sequelae and deaths in this group were clearly lower than for the antibiotic group, but the risk of deafness did not appear to be altered.

CONCLUSIONS

These results confirm the beneficial effect of dexamethasone reported earlier. The relatively frequent transient recurrences of fever and increased CRP when dexamethasone was interrupted suggest that the dose and/or duration of dexamethasone treatment should be modified.

摘要

背景

地塞米松联合抗生素治疗细菌性脑膜炎的有益效果仍存在争议。

患者与方法

1987年至1990年间,85名年龄在1个月至14岁的儿童因细菌性脑膜炎入院。他们接受相同的抗生素治疗10天(脑膜炎球菌性脑膜炎为7天)。1989年3月以后入院的44名儿童还接受了地塞米松治疗(0.15毫克/千克,每6小时一次,共4天);首次注射在抗生素治疗前进行。对临床指标(发热、神经系统表现、听力)和实验室数据[脑脊液蛋白、葡萄糖、乳酸、细胞及细菌计数;血液C反应蛋白(CRP)、血红蛋白、白细胞及血小板]进行统计学分析。

结果

抗生素联合地塞米松治疗组在48小时后脑脊液蛋白和乳酸水平的下降幅度明显大于单纯使用抗生素的儿童,且脑脊液葡萄糖在治疗开始后6小时即出现早期升高。地塞米松联合抗生素组的血液CRP水平在48小时内显著下降。该组的神经后遗症和死亡人数明显低于抗生素组,但耳聋风险似乎未改变。

结论

这些结果证实了早期报道的地塞米松的有益效果。地塞米松中断使用时发热和CRP相对频繁的短暂复发提示,应调整地塞米松治疗的剂量和/或疗程。

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验